SCOTTISH_RHEUMATOLOGY_ULT - Accounts


Company Registration Number SC504793 (Scotland)
SCOTTISH RHEUMATOLOGY ULTRASOUND GROUP
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2023
PAGES FOR FILING WITH REGISTRAR
SCOTTISH RHEUMATOLOGY ULTRASOUND GROUP
BALANCE SHEET
AS AT
31 JANUARY 2023
31 January 2023
- 1 -
2023
2022
£
£
£
£
Fixed assets
460
100
Current assets
10,066
13,901
Prepayments and accrued income
420
1,949
Creditors: amounts falling due within one year
(7,559)
(8,175)
Net current assets
2,927
7,675
Total assets less current liabilities
3,387
7,775
Net assets
3,387
7,775
Capital and reserves
3,387
7,775
Notes to the financial statements
1
Employees

The average number of persons, including directors, employed by the company during the year was as follows:

2023
2022
Number
Number
Employees
1
1
SCOTTISH RHEUMATOLOGY ULTRASOUND GROUP
BALANCE SHEET (CONTINUED)
AS AT
31 JANUARY 2023
31 January 2023
- 2 -

Scottish Rheumatology Ultrasound Group is a private company limited by shares incorporated in Scotland. The registered office is 34 Craigleith View, Edinburgh, Scotland, EH4 3JY.

For the year ended 31 January 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As the prior year financial statements were prepared in accordance with FRS102, transitional adjustments were considered to the current and prior period. After our review, it was concluded that no transitional adjustments were required.

The financial statements were approved and signed by the director and authorised for issue on 10 October 2023
N McKay
Director
Company Registration Number SC504793
2023-01-312022-02-01falseCCH SoftwareCCH Accounts Production 2023.200No description of principal activityN McKaySC5047932022-02-012023-01-31SC5047932023-01-31SC5047932022-01-31SC504793core:CurrentFinancialInstrumentscore:WithinOneYear2023-01-31SC504793core:CurrentFinancialInstrumentscore:WithinOneYear2022-01-31SC5047932021-06-012022-01-31SC504793bus:Director12022-02-012023-01-31SC504793bus:PrivateLimitedCompanyLtd2022-02-012023-01-31SC504793bus:SmallCompaniesRegimeForAccounts2022-02-012023-01-31SC504793bus:FRS1022022-02-012023-01-31SC504793bus:AuditExemptWithAccountantsReport2022-02-012023-01-31SC504793bus:FullAccounts2022-02-012023-01-31xbrli:purexbrli:sharesiso4217:GBP